Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Neviani

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Hematologic Malignancy Reports|January 11, 2014
Genetic events other than BCR-ABL1Paolo Neviani
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
SETting OP449 into the PP2A-activating drug familyPaolo Neviani, Danilo Perrotti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the wayDanilo Perrotti, Paolo Neviani
Frontiers in Medicine|August 11, 2015
Exosomic microRNAs in the Tumor MicroenvironmentPaolo Neviani, Muller Fabbri
The Lancet. Oncology|May 4, 2013
Protein phosphatase 2A: a target for anticancer therapyDanilo Perrotti, Paolo Neviani
Cancer Metastasis Reviews|January 24, 2008
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemiasDanilo Perrotti, Paolo Neviani
Drug Delivery|November 30, 2013
Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agentAmelia Parise, Andrea Milelli, Vincenzo Tumiatti, et al.
Mini Reviews in Medicinal Chemistry|November 7, 2014
Isothiocyanate synthetic analogs: biological activities, structure-activity relationships and synthetic strategiesAndrea Milelli, Carmela Fimognari, Nicole Ticchi, et al.
Investigative Ophthalmology & Visual Science|July 6, 2023
CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma AssociatedSarah Pike, Chen-Ching Peng, Paolo Neviani, et al.
Organic Letters|June 23, 2009
Self-assembled hexadecanitroxidePaolo Neviani, Elisabetta Mileo, Stefano Masiero, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Hematologic Malignancy Reports|January 11, 2014
Genetic events other than BCR-ABL1Paolo Neviani
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
SETting OP449 into the PP2A-activating drug familyPaolo Neviani, Danilo Perrotti
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the wayDanilo Perrotti, Paolo Neviani
Frontiers in Medicine|August 11, 2015
Exosomic microRNAs in the Tumor MicroenvironmentPaolo Neviani, Muller Fabbri
The Lancet. Oncology|May 4, 2013
Protein phosphatase 2A: a target for anticancer therapyDanilo Perrotti, Paolo Neviani
Cancer Metastasis Reviews|January 24, 2008
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemiasDanilo Perrotti, Paolo Neviani
Drug Delivery|November 30, 2013
Preparation, characterization and in vitro evaluation of sterically stabilized liposome containing a naphthalenediimide derivative as anticancer agentAmelia Parise, Andrea Milelli, Vincenzo Tumiatti, et al.
Mini Reviews in Medicinal Chemistry|November 7, 2014
Isothiocyanate synthetic analogs: biological activities, structure-activity relationships and synthetic strategiesAndrea Milelli, Carmela Fimognari, Nicole Ticchi, et al.
Investigative Ophthalmology & Visual Science|July 6, 2023
CD63/81 Small Extracellular Vesicles in the Aqueous Humor are Retinoblastoma AssociatedSarah Pike, Chen-Ching Peng, Paolo Neviani, et al.
Organic Letters|June 23, 2009
Self-assembled hexadecanitroxidePaolo Neviani, Elisabetta Mileo, Stefano Masiero, et al.
Pageof 5